Valeant says FDA denies approval to nail infection drug

(Reuters) - Canada drugmaker Valeant Pharmaceuticals International said on Tuesday that the U.S. Food and Drug Administration denied approval for its drug to treat onychomycosis, a fungal infection of the nail.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news